Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Subjects with a diagnosis of glaucoma will be handed out different quality of life related questionnaires and their score will be evaluated at baseline and 3-6 months after treatment or surgery was initiated/performed.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Study Arm (glaucoma) | subjects with a diagnosis of glaucoma |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| GQL-15 | Other | GQL-15 questionnaire |
| |
| Glaucoma Symptom Scale |
| Measure | Description | Time Frame |
|---|---|---|
| Ocular Surface Disease Index (OSDI) | The OSDI© is assessed on a scale of 0 to 4, with higher scores representing greater disability. The index demonstrates sensitivity and specificity in distinguishing between normal subjects and patients with dry eye disease. The OSDI© is a valid and reliable instrument for measuring dry eye disease (normal, mild to moderate, and severe) and effect on vision-related function. | At baseline and 3-6 months after glaucoma treatment (i.e. drops, SLT, or surgery) was initiated/performed. |
| Glaucoma Symptom Scale (GSS) | The Glaucoma Symptom Scale (GSS; Lee et al., 1998) was developed as a brief symptom survey specific for persons with glaucoma. The GSS consists of a 10-item scale developed from a modified version of a symptom checklist that address ocular complaints, some of a nonvisual nature and some of a visual nature, common to patients with glaucoma. Items are scored from 0 to 100, where 100 represents the absence of symptoms and 0 represents severe, bothersome symptoms. | At baseline and 3-6 months after glaucoma treatment (i.e. drops, SLT, or surgery) was initiated/performed. |
| National Eye Institute Visual Function Questionaire (NEI VFQ) | Vision-specific instrument designed to measure vision-related quality of life (VRQoL) in adults, incorporating body, activity, and participation content according to the WHO ICF Framework in order to measure the effects of a variety of ocular conditions on daily functioning and QOL. It was originally designed as a 51-point questionnaire and is currently available in both self-administered and interview-based formats. The raw scores are converted to a 0-100 scale; after reverse scoring, a high score (100) indicates better vision-specific quality of life, while a low score (0) indicates poor function. | At baseline and 3-6 months after glaucoma treatment (i.e. drops, SLT, or surgery) was initiated/performed. |
| Glaucoma Quality of Life-15 (GQL-15) | The Glaucoma Quality of Life-15 (GQL-15) is a validated 15-item, self-report questionnaire used to measure visual disability and quality of life (QoL) in glaucoma patients. It covers four key areas-peripheral vision, central/near vision, glare/dark adaptation, and outdoor mobility-using a 5-point scale (1=no difficulty to 5=severe difficulty). |
Not provided
Not provided
Inclusion:
Exclusion:
Not provided
Not provided
Not provided
any patient with a diagnosis of glaucoma treated or evaluated for glaucoma at the Dept. of Ophthalmology & Visual Sciences, University of Iowa, Iowa City, IA, USA
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Marc Toeteberg-Harms, MD | Contact | +1 319 356 3938 | marc-toeteberg-harms@uiowa.edu | |
| Helen Gomez Study Coordinator | Contact | +1 319 356 3938 | helen-gomez@uiowa.edu |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Iowa, Dept. of Ophthalmology & Visual Sciences | Recruiting | Iowa City | Iowa | 52242 | United States |
data will be stored anonymously without patient identifier. It can be shared on a case by case decision.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005901 | Glaucoma |
| ID | Term |
|---|---|
| D009798 | Ocular Hypertension |
| D005128 | Eye Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Other |
GSS questionnaire |
|
| NEI Vision Function Questionnaire | Other | Vision function questionnaire |
|
| Ocular Surface Disease Index | Other | OSDI questionnaire |
|
| At baseline and 3-6 months after glaucoma treatment (i.e. drops, SLT, or surgery) was initiated/performed. |